STOCK TITAN

Ambev (ABEV) board sells ADRs as management receives restricted shares in July 2026

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Ambev S.A. reported management and related-person transactions in its securities for July 2026 under Brazilian CVM Instruction 44. The board of directors’ group sold 468,040 ADRs at R$15.646 each through Corretora J.P. Morgan, totaling R$7,322,953.84, reducing its ADR balance to zero while maintaining 30,679,627 common shares. Management received a delivery of 203,463 restricted common shares directly from the company at a reference price of R$16.200, increasing its common share position to 3,501,801 shares and keeping 19,790 ADRs. The fiscal council’s holdings of 2,500 common shares remained unchanged during the period.

Positive

  • None.

Negative

  • None.
Board ADRs sold 468,040 ADRs Board-related group sale in July 2026
Board ADR sale price R$15.646 Per-ADR price for 468,040 ADRs sold
Board ADR sale volume R$7,322,953.84 Total volume from ADR sale in July 2026
Restricted shares delivered to management 203,463 shares Delivery of restricted common shares in July 2026
Restricted share reference price R$16.200 Per-share reference price for restricted share delivery
Management common shares after transactions 3,501,801 shares Management group final common share balance July 2026
Board common shares after transactions 30,679,627 shares Board-related group final common share balance July 2026
Fiscal council common shares 2,500 shares Fiscal council holdings unchanged in July 2026
ADR financial
"Shares | Common | 30,679,627 | ADR | Common | 468,040"
An American Depositary Receipt (ADR) is a financial certificate that lets investors buy shares of a foreign company through U.S. stock markets, similar to buying a local wrapper that represents the underlying foreign shares. ADRs matter because they make investing in overseas companies easier and more liquid by trading in U.S. dollars and under U.S. market rules, while still carrying currency, regulatory, and country-specific risks that can affect share value.
Restricted Shares financial
"Direct with Company | Delivery of Restricted Shares | 02 | 203,463"
Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.
Fiscal Council financial
"Group and Related Persons | ( ) Management | ( X ) Fiscal Council"
CVM Instruction # 44/2021 regulatory
"in compliance with Article 11 - CVM Instruction # 44/2021"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider securities transactions did Ambev (ABEV) report for July 2026?

Ambev reported a sale of 468,040 ADRs by the board group and a delivery of 203,463 restricted shares to management. The fiscal council’s 2,500 common shares position did not change during the month.

What restricted share transaction involving Ambev (ABEV) management occurred in July 2026?

Management received a delivery of 203,463 restricted common shares directly from Ambev at a reference price of R$16.200 per share, for a total of R$3,296,100.60. This increased management’s common share holdings to 3,501,801 shares.

What were Ambev (ABEV) management’s share and ADR balances after July 2026 transactions?

After the July 2026 transactions, management’s reported holdings were 3,501,801 common shares and 19,790 ADRs. The increase in common shares reflects the 203,463 restricted shares delivered by the company during the month.

Did Ambev (ABEV) fiscal council members trade company shares in July 2026?

No trades were reported for the fiscal council group in July 2026. Their position remained at 2,500 common shares throughout the month, with no securities or derivatives transactions disclosed for this group.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 6-K

 

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

 

For the month of August, 2026

Commission File Number 1565025

 


 

AMBEV S.A.

(Exact name of registrant as specified in its charter)

 

AMBEV S.A.

(Translation of Registrant's name into English)

 

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


Form 20-F ___X___ Form 40-F _______

 Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____

 
 

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 44/2021

 

From July 1st to 31st, 2026 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 44/2021 (1):

 

Company Name: Ambev S.A.  
Group and Related Persons

( X )

Board of Directors

( )

Management

( )

Fiscal Council

( )

Technical and Consulting Committees

 
Initial Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 30,679,627  
ADR Common 468,040  
Transactions in the month  
Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3)  
ADR Common Corretora J.P. Morgan Sell 30 468,040 15.64600 7,322,953.84  
                 
                 
                 
                 
                 
                 
Final Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 30,679,627  
ADR Common 0  
                         

 

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 44/2021, send a statement with that information.

 

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(3) Quantity multiplied by price.

 

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

 

Each ADR is equivalent to 1 (one) share.

 

 

 
 

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 44/2021

From July 1st to 31st, 2026 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 44/2021 (1):

 

Company Name: Ambev S.A.  
Group and Related Persons

( )

Board of Directors

( X )

Management

( )

Fiscal Council

( )

Technical and Consulting Committees

 
Initial Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 3,298,338  
ADR Common 19,790  
Transactions in the month  
Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3)  
Shares Common Direct with Company Delivery of Restricted Shares 02 203,463 16.20000 3,296,100.60  
                 
                 
                 
                 
                 
                 
Final Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 3,501,801  
ADR Common 19,790  
                           

 

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 44/2021, send a statement with that information.

 

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(3) Quantity multiplied by price.

 

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

 

Each ADR is equivalent to 1 (one) share.

 
 

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 44/2021

 

 

From July 1st to 31st, 2026 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 44/2021 (1):

 

Company Name: Ambev S.A.  
Group and Related Persons

( )

Board of Directors

( )

Management

( X )

Fiscal Council

( )

Technical and Consulting Committees

 
Initial Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 2,500  
Transactions in the month  
Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3)  
                 
                 
Final Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 2,500  
                           

 

 

(1)When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 44/2021, send a statement with that information.

 

(2)Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(3) Quantity multiplied by price.

 

 

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

 

 

 

 

 

 

 

 
 

SIGNATURE



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: August 10, 2026

     
  AMBEV S.A.
     
  By:  /s/ Guilherme Fleury de Figueiredo Ferraz Parolari
 

Guilherme Fleury de Figueiredo Ferraz Parolari

Chief Financial and Investor Relations Officer